Serious, rare risks include pancreatitis and gallbladder disease, which is why strict medical supervision by a healthcare professional is non-negotiable
GLP-1 (glucagon-like peptide-1
3 Medicaid coverage for weight-loss drugs Medicaid is required to provide coverage for any FDA-approved drug that meets the federal definition of a covered outpatient drug and for which the manufacturer has entered into a rebate agreement with the Department of Health and Human Services Secretary (i.e., the Medicaid Drug Rebate Program [MDRP])
Erratic timing dosing at 9am one week and 6pm the next prevents this adaptation and can increase dropout risk
The researchers matched adults starting treatment with GLP-1 receptor agonists 1:1 with those initiating DPP-4 inhibitors based on age, sex, race, hemoglobin A1c levels, BMI, underlying comorbidities, commonly used medications, and diabetes therapy
Approval ensures that the treatment has undergone rigorous testing for safety and effectiveness, with standardized dosing protocols in place